Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

1.3K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.1K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.4K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Posterior cerebellar degeneration associates with executive dysfunction in multiple system atrophy: a voxel-based and atlas-based morphometric study.

Clinical parkinsonism & related disorders·2026
Same author

Five-year change in brain metabolism across the spectrum of cognitive impairment in older adults: a quantitative MRI study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

The SPN-4 Rbfox RNA-binding protein selects maternal mRNAs for CCR4-NOT-dependent clearance in early Caenorhabditis elegans embryos.

Development (Cambridge, England)·2026
Same author

Hippocampal subregional texture features associated with Alzheimer's disease severity and cognition.

Brain communications·2026
Same author

The 30<sup>th</sup> Scientific Conference of the Society on NeuroImmune Pharmacology in Annapolis, Maryland, May 3<sup>rd</sup> - 6<sup>th</sup>, 2026.

NeuroImmune pharmacology and therapeutics·2026
Same author

Correlation between changes in substructure diffusion tensor imaging and neurocognitive outcomes for pediatric brain tumor survivors.

Neuro-oncology advances·2026
Same journal

Study on the Effects and Mechanisms of Resveratrol in Improving Cognitive Impairment in Aβ<sub>1-42</sub>-Induced Alzheimer's Disease Model Mice.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2026
Same journal

Δ<sup>9</sup>-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Diminish CD16<sup>+</sup> Monocyte-Induced Astrocyte Inflammation, while THC Uniquely Inhibits Monocyte Chemotaxis Independent of HIV Status.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2026
Same journal

Neuroimmune Correlates of HIV and Marijuana Use: Peripheral Biomarkers and Cognitive Function.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2026
Same journal

Therapeutic Effects of Zhilong Huoxue Tongyu Capsule on Oxidative Stress and Neuroprotection in a Rat Model of Intracerebral Hemorrhage.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2026
Same journal

Neuropeptide Y as a Neuro-Immune Checkpoint in Cancer.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2026
Same journal

Natural Killer Cells: Dual Regulators and Therapeutic Targets in Multiple Sclerosis Immunopathogenesis.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2026
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.9K

Brain Microstructure and Impulsivity Differ between Current and Past Methamphetamine Users.

Tamara Andres1, Thomas Ernst1, Kenichi Oishi2

  • 1Neuroscience and MR Research Program, John A. Burn School of Medicine, University of Hawaii at Manoa, Honolulu, HI, USA.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|May 4, 2016
PubMed
Summary
This summary is machine-generated.

Current and past methamphetamine users show distinct brain differences. These findings highlight the need to differentiate user groups in research to understand neuroinflammation and neurodegeneration stages.

Keywords:
DTIImpulsivityMethamphetamineStriatumWhite matter

More Related Videos

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

8.0K
Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior
10:05

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior

Published on: September 16, 2015

15.1K

Related Experiment Videos

Last Updated: Mar 21, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.9K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

8.0K
Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior
10:05

Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior

Published on: September 16, 2015

15.1K

Area of Science:

  • Neuroscience
  • Addiction Research
  • Neuroimaging

Background:

  • Methamphetamine (Meth) use disorder is a global health issue.
  • Meth users exhibit elevated impulsivity and neurological abnormalities.
  • Differences in brain structure may exist between current and past Meth users.

Purpose of the Study:

  • To compare impulsivity, depressive symptoms, and brain microstructure in current Meth users, past Meth users, and controls.
  • To investigate differences in the striatum and white matter tracts using diffusion tensor imaging (DTI).

Main Methods:

  • Assessed 94 participants: 27 current Meth users, 32 past Meth users, and 35 controls.
  • Measured impulsivity and depressive symptoms.
  • Utilized DTI to analyze fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) in specific brain regions.

Main Results:

  • Current Meth users reported the highest impulsivity.
  • Both Meth user groups displayed larger striatal volumes compared to controls.
  • Past Meth users showed higher striatal FA and lower MD, suggesting increased iron content and dendritic spine density.
  • Current Meth users had higher white matter AD, indicative of axonal swelling and inflammation.
  • Past Meth users exhibited lower white matter AD, potentially due to reactive gliosis.

Conclusions:

  • Brain microstructural abnormalities in Meth users vary based on recency of use, reflecting different stages of neuroinflammation or neurodegeneration.
  • Treating current and past Meth users as a single group may introduce significant variability in research findings.
  • Longitudinal studies are crucial to elucidate the relationship between Meth use duration and brain microstructure changes.